Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

Income Statement 
Quarterly Data

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

UnitedHealth Group Inc., consolidated income statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Premiums 76,483 77,442 76,897 77,988 73,228 72,339 72,474 72,786 64,700 64,491 63,896 64,070 57,547 56,967 56,233 55,486 50,581 50,863 49,394 50,640
Products 13,475 12,631 12,211 11,909 11,311 10,354 10,651 10,267 9,398 9,190 9,496 9,340 8,961 8,703 8,433 8,340 8,690 8,777 8,247 8,431
Services 9,298 9,104 8,750 8,888 8,709 8,671 8,663 8,080 7,834 6,700 6,645 6,372 6,422 6,164 6,099 5,918 5,751 5,124 4,156 4,985
Revenues, customers 99,256 99,177 97,858 98,785 93,248 91,364 91,788 91,133 81,932 80,381 80,037 79,782 72,930 71,834 70,765 69,744 65,022 64,764 61,797 64,056
Medical costs (67,035) (65,957) (65,458) (65,735) (62,231) (59,550) (60,268) (59,845) (53,591) (52,635) (52,093) (52,523) (48,159) (47,302) (46,546) (44,904) (42,082) (41,636) (34,678) (41,000)
Cost of products sold (12,464) (11,834) (11,340) (11,056) (10,194) (9,423) (9,748) (9,405) (8,314) (8,306) (8,596) (8,487) (8,000) (7,802) (7,660) (7,572) (7,622) (7,935) (7,501) (7,687)
Cost of revenues (79,499) (77,791) (76,798) (76,791) (72,425) (68,973) (70,016) (69,250) (61,905) (60,941) (60,689) (61,010) (56,159) (55,104) (54,206) (52,476) (49,704) (49,571) (42,179) (48,687)
Gross profit 19,757 21,386 21,060 21,994 20,823 22,391 21,772 21,883 20,027 19,440 19,348 18,772 16,771 16,730 16,559 17,268 15,318 15,193 19,618 15,369
Investment and other income 1,551 1,643 997 1,011 1,179 997 1,115 798 855 513 295 367 813 503 556 452 445 351 341 365
Operating costs (12,494) (13,280) (13,162) (14,077) (13,339) (13,855) (13,809) (13,625) (13,009) (11,663) (11,709) (11,401) (11,272) (10,725) (10,359) (10,223) (11,514) (10,174) (10,001) (10,015)
Depreciation and amortization (1,041) (1,041) (1,020) (997) (974) (1,007) (1,021) (970) (982) (828) (802) (788) (771) (796) (778) (758) (732) (719) (717) (723)
Earnings from operations 7,773 8,708 7,875 7,931 7,689 8,526 8,057 8,086 6,891 7,462 7,132 6,950 5,541 5,712 5,978 6,739 3,517 4,651 9,241 4,996
Interest expense (1,003) (1,074) (985) (844) (830) (834) (828) (754) (676) (516) (467) (433) (431) (422) (410) (397) (401) (395) (430) (437)
Loss on sale of subsidiary and subsidiaries held for sale 21 (20) (1,225) (7,086)
Earnings before income taxes 6,791 7,614 5,665 1 6,859 7,692 7,229 7,332 6,215 6,946 6,665 6,517 5,110 5,290 5,568 6,342 3,116 4,256 8,811 4,559
Provision for income taxes (1,007) (1,356) (1,244) (1,222) (1,184) (1,654) (1,572) (1,558) (1,307) (1,562) (1,466) (1,369) (919) (1,099) (1,196) (1,364) (764) (1,000) (2,115) (1,094)
Net earnings (loss) 5,784 6,258 4,421 (1,221) 5,675 6,038 5,657 5,774 4,908 5,384 5,199 5,148 4,191 4,191 4,372 4,978 2,352 3,256 6,696 3,465
Earnings attributable to noncontrolling interests (241) (203) (205) (188) (220) (197) (183) (163) (147) (122) (129) (121) (120) (105) (106) (116) (140) (84) (59) (83)
Net earnings (loss) attributable to UnitedHealth Group common shareholders 5,543 6,055 4,216 (1,409) 5,455 5,841 5,474 5,611 4,761 5,262 5,070 5,027 4,071 4,086 4,266 4,862 2,212 3,172 6,637 3,382

Based on: 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).

Income statement item Description The company
Revenues, customers Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. UnitedHealth Group Inc. revenues, customers increased from Q2 2024 to Q3 2024 and from Q3 2024 to Q4 2024.
Earnings from operations The net result for the period of deducting operating expenses from operating revenues. UnitedHealth Group Inc. earnings from operations increased from Q2 2024 to Q3 2024 but then decreased significantly from Q3 2024 to Q4 2024.
Earnings before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. UnitedHealth Group Inc. earnings before income taxes increased from Q2 2024 to Q3 2024 but then slightly decreased from Q3 2024 to Q4 2024.
Net earnings (loss) attributable to UnitedHealth Group common shareholders The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. UnitedHealth Group Inc. net earnings (loss) attributable to UnitedHealth Group common shareholders increased from Q2 2024 to Q3 2024 but then slightly decreased from Q3 2024 to Q4 2024.